(Q43735561)

26 November 2017

title

The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial (English)

1 reference

26 November 2017

1 reference

Janika Kõrv

5

0 references

Dalius Jatuzis

Dalius Jatuzis

4

0 references

Stephan Lüders

Stephan Lüders

6

0 references

Gordon Murray

Gordon D Murray

7

0 references

Vincent N Thijs

Vincent Thijs

11

0 references

Philip M W Bath

Philip M W Bath

2

0 references

Helle K Iversen

1 reference

ORCID Public Data File 2021

author name string

Else Charlotte Sandset

1

1 reference

26 November 2017

Gudrun Boysen

3

1 reference

26 November 2017

Przemyslaw S Richter

8

1 reference

26 November 2017

Risto O Roine

9

1 reference

26 November 2017

Andreas Terént

10

1 reference

26 November 2017

Eivind Berge

12

1 reference

26 November 2017

SCAST Study Group

13

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 February 2011

1 reference

26 November 2017

1 reference

26 November 2017

volume

377

1 reference

26 November 2017

issue

9767

1 reference

26 November 2017

page(s)

741-750

1 reference

Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Blood pressure and clinical outcomes in the International Stroke Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

High blood pressure in acute stroke and subsequent outcome: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Acute hypertensive response in patients with stroke: pathophysiology and management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Vasoactive drugs for acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the A

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care a

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Vascular protection with candesartan after experimental acute stroke in hypertensive rats: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Angiotensin Receptor Blockade in Acute Stroke. the Scandinavian Candesartan Acute Stroke Trial: Rationale, Methods and Design of a Multicentre, Randomised- and Placebo-Controlled Clinical Trial (NCT00120003)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Recovery of motor function after stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Predictors of stroke outcome using objective measurement scales.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Could stroke trials be missing important treatment effects?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Can We Improve the Statistical Analysis of Stroke Trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

A simulation study evaluating approaches to the analysis of ordinal outcome data in randomized controlled trials in traumatic brain injury: results from the IMPACT Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Design and analysis of phase III trials with ordered outcome scales: the concept of the sliding dichotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

A sharper Bonferroni procedure for multiple tests of significance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

The Second (Main) Phase of an Open, Randomised, Multicentre Study to Investigate the Effectiveness of an Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (Interact2)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Isradipine in patients with acute ischaemic cerebral infarction. An overview of the ASCLEPIOS Programme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

A randomized, double-blind, placebo-controlled trial of nimodipine in acute ischemic hemispheric stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Effect of intravenous nimodipine on blood pressure and outcome after acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960104-9

7 January 2021

10.1016/S0140-6736(11)60104-9

Identifiers

DOI

1 reference

26 November 2017

1 reference